Related Experiment Video
Updated: Jun 14, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease
C P Kovesdy1, J E Anderson, K Kalantar-Zadeh
1Division of Nephrology, Salem Veterans Affairs Medical Center, 1970 Roanoke Blvd., Salem, VA 24153, USA. csaba.kovesdy@va.gov
Insights
Elevated serum phosphorus levels in patients with chronic kidney disease (CKD) are linked to higher mortality. This study highlights the cumulative impact of high phosphorus on mortality risk in non-dialysis dependent CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Public Health
Background:
- Hyperphosphatemia is a known risk factor for mortality and end-stage renal disease (ESRD) in non-dialysis dependent chronic kidney disease (NDD-CKD).
- Previous studies have not fully accounted for the cumulative effects of elevated serum phosphorus over time in NDD-CKD patients.
Purpose of the Study:
- To investigate the association between cumulative serum phosphorus levels and mortality and kidney function decline in NDD-CKD.
- To assess the impact of both baseline and time-averaged phosphorus levels on adverse outcomes.
Main Methods:
- A cohort of 713 males with moderate to advanced NDD-CKD was analyzed.
- Cox and mixed-effects models were used to examine associations between serum phosphorus (baseline and time-averaged) and outcomes.
- Outcomes included all-cause mortality, a composite of mortality or ESRD, and the rate of estimated glomerular filtration rate (eGFR) decline.
Main Results:
- Higher baseline and time-averaged serum phosphorus levels were significantly associated with increased mortality and the composite outcome.
- A 1 mg/dl increase in time-averaged serum phosphorus correlated with a 1.56-fold increased hazard of all-cause mortality.
- While unadjusted analyses showed an association between higher phosphorus and faster eGFR decline, this did not remain significant after multivariable adjustments.
Conclusions:
- The cumulative burden of hyperphosphatemia is a significant predictor of mortality in patients with moderate and advanced NDD-CKD.
- Further clinical trials are warranted to evaluate the efficacy of serum phosphorus reduction strategies on improving mortality in this patient population.
Background/Aims:
Hyperphosphatemia is associated with higher mortality and increased incidence of end-stage renal disease in patients with non-dialysis dependent CKD (NDD-CKD), but there has not been a concomitant assessment of mortality and progressive kidney disease that would also account for cumulative effects of hyperphosphatemia.
Methods:
In order to account for the cumulative effects of abnormal serum phosphorus we examined associations of not only baseline, but also time-averaged serum phosphorus levels with all-cause mortality, the composite of mortality or ESRD and the slopes of estimated glomerular filtration rate (eGFR), by using Cox models and mixed effects models in a contemporary cohort of 713 males with moderate and advanced NDD-CKD.
Results:
Higher baseline and time-averaged serum phosphorus were both associated with mortality and with the composite outcome. A 1 mg/dl higher time-averaged serum phosphorus was associated with a multivariable adjusted hazard ratio of all-cause mortality (95% CI) of 1.56 (1.19 - 2.05), p = 0.001. Higher serum phosphorus was associated with a steeper slope of eGFR in unadjusted analyses, but this association became non-significant after multivariable adjustments.
Conclusion:
The cumulative burden of hyperphosphatemia is associated with increased mortality in patients with moderate and advanced NDD-CKD. Clinical trials are needed to determine if lowering serum phosphorus can result in improved mortality in this population.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Serum Studies: Renal Function Tests
Acute Kidney Injury III: Clinical Manifestations
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Chronic Kidney Disease I: Introduction

